株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオバンキングの世界市場:2017-2021年

Global Biobanking Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 248654
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.10円で換算しております。
Back to Top
バイオバンキングの世界市場:2017-2021年 Global Biobanking Market 2017-2021
出版日: 2017年03月13日 ページ情報: 英文 70 Pages
概要

バイオバンクは、医学研究に利用できる生物学的素材や関連データを組織的・計画的に保存する機構と定義することが出来ます。医療の技術革新に欠かせない生物学試料の例としては、体組織、体液(血清、血液、尿、穿刺液ほか)、関連誘導体(RNA、DNA、タンパク質)、細胞などが挙げられます。その世界市場は今後数年にわたって8.84%の複合年間成長率で拡大する見込み。

当レポートでは、バイオバンキングの世界市場に注目し、業界エキスパートの協力を得ながら、2017-2021年の期間を対象に取扱い価額の推移を地域(南北アメリカ、アジア太平洋地域、欧州・中東・アフリカ)に分けて分析・予測するほか、発展への推進要因や課題、動向、主要供給企業など最新の調査情報をまとめています。

第1章 エグゼクティブサマリー

第2章 レポートの対象範囲

第3章 調査方法

第4章 イントロダクション

  • 市場の重要ハイライト

第5章 バイオバンク - 概要

  • バイオバンクの種類
  • 商業バイオバンクの分類
  • 商業バイオバンク一覧

第6章 保存条件

  • 制御室温
  • 冷蔵
  • 冷凍
  • 超低温
  • 極低温LN2

第7章 市場環境

  • 市場概要
  • ファイブフォース分析

第8章 バイオバンクの資金調達と財政安定性

  • コスト回収モデルへの移行

第9章 バイオバンクの協調

第10章 市場セグメンテーション - 製品別

  • バイオバンキング設備の世界市場
  • 市場の規模と予測
  • バイオバンク用消耗材の世界市場
  • 市場の規模と予測

第11章 市場セグメンテーション - 試料別

第12章 地域別セグメンテーション

  • 南北アメリカにおけるバイオバンキング市場
  • 欧州・中東・アフリカにおけるバイオバンキング市場
  • アジア太平洋地域におけるバイオバンキング市場

第13章 市場推進要因

  • オーダーメード医療への需要増
  • 資金の増大
  • 自動化による効率向上で見込まれる需要増
  • 研究費の削減

第14章 推進要因の影響度

第15章 市場課題

  • 倫理問題
  • 標準手続きの未整備に伴う臓器保存の限界
  • 制約される試料入手
  • 社会的信頼の欠如

第16章 推進要因および課題の影響度

第17章 市場動向

  • バイオバンク利用による幹細胞保存の出現
  • 高まる希少疾患研究への注目度
  • M&Aの増加
  • 新興国で浮上するバイオ保険

第18章 事業環境

  • 競合状況
  • 重要ニュース

第19章 主要供給企業分析

  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR
  • その他有力企業

第20章 付録

  • 略語一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR12235

About biobanking

A biobank can be defined as an organized and programed storage of biological materials and corresponding data that can be used in healthcare research. The biological samples vital for medical innovation include tissue, body fluids (such as serum, blood, urine, or fluids from punctures), related derivatives (RNA, DNA, or proteins), and cells.

Technavio's analysts forecast the global biobanking market to grow at a CAGR of 8.84% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global biobanking market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of biobanking.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Biobanking Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR

Other Prominent Vendors

  • Askion
  • AstridBio Technologies
  • Autoscribe Informatics
  • B&C Group
  • BioBank
  • BioCryo
  • BIOGENIC
  • BioKryo
  • BioLife Solutions
  • Biomatrica
  • BioreclamationIVT
  • BioRep
  • Biorep Technologies
  • BioStorage Technologies
  • BioTillion
  • bluechiip
  • Brady Worldwide
  • Brooks Life Science Systems
  • Cell & Co Bioservices
  • Cesca Therapeutics
  • Chart Industries
  • CloudLIMS
  • Core Dynamics
  • Cryo Bio System
  • Cryogatt
  • Cryotherm
  • CryoXtract
  • CSols
  • Custom Bio Genic Systems
  • Dataworks Development
  • DNA Genotek
  • Excilone
  • FluidX
  • Greiner Bio-One International
  • HAMILTON storage
  • Indivumed
  • labmode
  • LabVantage Solutions
  • LGC Genomics
  • LiCONiC
  • LVL Technologies
  • Micronic
  • Modul-Bio
  • NorayBio
  • Ocimum Biosolutions
  • Panasonic Biomedical Sales Europe BV
  • Princeton CryoTech
  • Promega
  • QIAGEN
  • RURO
  • SINTESY
  • SOL Spa
  • So-Low Environmental Equipment
  • Sysmex
  • TECHNIDATA
  • Tissue Solutions
  • Trans-Hit Bio
  • TRINEAN
  • Tutela Monitoring Systems
  • Wildcat Laboratory Solutions
  • Ziath

Market driver

  • Increase in funding
  • For a full, detailed list, view our report

Market challenge

  • Ethical issues
  • For a full, detailed list, view our report

Market trend

  • Emergence of stem cells storage in biobanks
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Biobanks: An overview

  • Types of biobanks
  • Classification of commercial biobanks
  • List of commercial biobanks

PART 06: Storage conditions

  • Controlled room temperature
  • Refrigeration
  • Frozen
  • Ultra-low
  • Cryogenic LN2

PART 07: Market landscape

  • Market overview
  • Five forces analysis

PART 08: Biobank funding and financial stability

  • Moving toward cost recovery model

PART 09: Harmonization of biobanking

PART 10: Market segmentation by product

  • Global biobanking equipment market
  • Market size and forecast
  • Global biobanking consumables market
  • Market size and forecast

PART 11: Market segmentation by sample

PART 12: Geographical segmentation

  • Biobanking market in Americas
  • Biobanking market in EMEA
  • Biobanking market in APAC

PART 13: Market drivers

  • Growing demand for personalized medicine
  • Increase in funding
  • Increase in efficiency through automation will increase demand
  • Reduction in research costs

PART 14: Impact of drivers

PART 15: Market challenges

  • Ethical issues
  • Lack of standardized procedures coupled with limitations in organ preservation
  • Restricted access to samples
  • Lack of public trust

PART 16: Impact of drivers and challenges

PART 17: Market trends

  • Emergence of stem cells storage in biobanks
  • Increasing focus on rare disease research
  • Increasing M&A
  • Emergence of bio assurance in emerging economies

PART 18: Vendor landscape

  • Competitive scenario
  • Key news

PART 19: Key vendor analysis

  • Beckman Coulter
  • BioCision
  • Taylor-Wharton
  • Tecan Group
  • Thermo Fisher Scientific
  • VWR
  • Other prominent vendors

PART 20: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Workflow of a typical biobank
  • Exhibit 02: Topology of biobanks
  • Exhibit 03: Snapshot of global biobanking market
  • Exhibit 04: Global biobanking market 2016-2021 ($ millions)
  • Exhibit 05: Opportunity analysis of global biobanking market
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Revenue models of biobanks
  • Exhibit 08: Organizations and their initiatives for biobank harmonization
  • Exhibit 09: Key factors involved in harmonization of biobanks
  • Exhibit 10: Key focus areas in harmonization of biobanks
  • Exhibit 11: Organizations and initiatives in harmonizing science and infrastructure of biobanks
  • Exhibit 12: Initiatives in biobanking resource tools and databases
  • Exhibit 13: Global biobanking market segmentation by product
  • Exhibit 14: Global biobanking market by product 2016 and 2021
  • Exhibit 15: Global biobanking market by product 2016
  • Exhibit 16: Global biobanking market segmentation by product type: Growth lifecycle analysis 2016
  • Exhibit 17: Global biobanking market by product 2016-2021 ($ millions)
  • Exhibit 18: Global biobanking market by product 2016-2021
  • Exhibit 19: Global biobanking equipment market 2016-2017 ($ millions)
  • Exhibit 20: Properties of an efficient sample management system:
  • Exhibit 21: List of key automated sample storage products
  • Exhibit 22: List of key automated liquid handling and robotics storage sample products
  • Exhibit 23: Commercial software used in biobanks
  • Exhibit 24: Open-source software used in biobanks
  • Exhibit 25: Global automation equipment market 2016-2021 ($ millions)
  • Exhibit 26: Global biobanking non-automation equipment market 2016-2021 ($ millions)
  • Exhibit 27: Global biobanking consumables market 2016-2021 ($ millions)
  • Exhibit 28: Global biobanking market by sample type
  • Exhibit 29: Global biobanking market by sample 2016
  • Exhibit 30: Global biobanking market by geography 2016 and 2021(%)
  • Exhibit 31: Global biobanking market by geography 2016
  • Exhibit 32: Global biobanking market by geography: Growth lifecycle analysis
  • Exhibit 33: Global biobanking market by geography 2016-2021 ($ millions)
  • Exhibit 34: Global biobanking market by geography 2016-2021 (%)
  • Exhibit 35: Biobanking market in Americas 2016-2021 ($ millions)
  • Exhibit 36: Biobanks in Americas
  • Exhibit 37: Biobanking market in EMEA 2016-2021 ($ millions)
  • Exhibit 38: Biobanks in EMEA
  • Exhibit 39: Biobanking market in APAC 2016-2021 ($ millions)
  • Exhibit 40: List of biobanks in APAC
  • Exhibit 41: Impact of drivers
  • Exhibit 42: Impact of drivers and challenges
  • Exhibit 43: Rare disease research activities
  • Exhibit 44: Major biobanks in emerging countries
  • Exhibit 45: Competitive structure analysis of global biobanking market 2016
  • Exhibit 46: Competitive scenario of vendors in global biobanking market
  • Exhibit 47: Market share analysis of global biobanking market 2016
  • Exhibit 48: Competitive landscape analysis of global biobanking market 2016
  • Exhibit 49: Market penetration of various manufacturers in global biobanking market 2016
  • Exhibit 50: Strategic factors determining success for companies in global biobanking market
  • Exhibit 51: Key highlights of Beckman Coulter
  • Exhibit 52: Beckman Coulter: Strength assessment
  • Exhibit 53: Beckman Coulter: Strategy assessment
  • Exhibit 54: Beckman Coulter: Opportunity assessment
  • Exhibit 55: Key highlights of BioCision
  • Exhibit 56: BioCision: Strength assessment
  • Exhibit 57: BioCision: Strategy assessment
  • Exhibit 58: BioCision: Opportunity assessment
  • Exhibit 59: Key highlights of Taylor-Wharton
  • Exhibit 60: Taylor-Wharton: Strength assessment
  • Exhibit 61: Taylor-Wharton: Strategy assessment
  • Exhibit 62: Taylor-Wharton: Opportunity assessment
  • Exhibit 63: Key highlights of Tecan Group
  • Exhibit 64: Tecan Group: Strength assessment
  • Exhibit 65: Tecan Group: Strategy assessment
  • Exhibit 66: Tecan Group opportunity assessment
  • Exhibit 67: Key highlights: Thermo Fisher Scientific
  • Exhibit 68: Thermo Fisher Scientific: Strength assessment
  • Exhibit 69: Thermo Fisher Scientific: Strategy assessment
  • Exhibit 70: Thermo Fisher Scientific: Opportunity assessment
  • Exhibit 71: Key highlights of VWR
  • Exhibit 72: VWR: Strength assessment
  • Exhibit 73: VWR: Strategy assessment
  • Exhibit 74: VWR: Opportunity assessment
Back to Top